Targeting the VEGF Axis in Advanced NSCLC

Videos — July 6, 2016

Featuring:

Benjamin P. Levy, MD, reviews current and emerging roles for agents that target the VEGF axis in advanced non–small-cell lung cancer and expresses his belief that a lot of work needs to be done to define the optimal space for these drugs.

Related Articles